Twist Bioscience to Present at Upcoming Investor Conferences

Rhea-AI Summary

Twist Bioscience Corporation (NASDAQ: TWST) announced key presentations by CEO Emily M. Leproust and CFO Jim Thorburn at upcoming investor conferences. They will participate in the Cowen 43rd Annual Healthcare Conference on March 6-7, 2023, with a fireside chat on March 7 at 1:30 p.m. ET. The Barclays Global Healthcare Conference will occur on March 14, 2023, featuring a fireside chat at 2:05 p.m. ET. Both events will be webcasted live and available for replay for 30 days. Twist Bioscience specializes in synthetic DNA manufacturing, with applications across healthcare, agriculture, and more.

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)-- Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced that Emily M. Leproust, Ph.D., CEO and co-founder of Twist Bioscience, and Jim Thorburn, CFO of Twist Bioscience, will present at the following upcoming investor conferences:

• Cowen 43^rd Annual Healthcare Conference in Boston, MA;
  • Fireside chat on Tuesday, March 7 at 1:30 p.m. Eastern Time.
  • SynBio & AI Driven Drug Discovery Panel: Monday, March 6 at 4:40 p.m. Eastern Time.
  • Synthetic Biology Enabling Tools Panel: Tuesday, March 7 at 4:40 p.m. Eastern Time.

• Barclays Global Healthcare Conference on Tuesday, March 14 in Miami, FL; fireside chat at 2:05 p.m. Eastern Time.

The Cowen fireside chat and panels and Barclays fireside chat will be webcast live and can be accessed by visiting the “Investor Calendar” page of the investor relations section of the company's website here. A replay of the fireside chats will be archived for a period of 30 days following the conclusion of the live events.

About Twist Bioscience Corporation

Twist Bioscience is a leading and rapidly growing synthetic biology and genomics company that has developed a disruptive DNA synthesis platform to industrialize the engineering of biology. The core of the platform is a proprietary technology that pioneers a new method of manufacturing synthetic DNA by “writing” DNA on a silicon chip. Twist is leveraging its unique technology to manufacture a broad range of synthetic DNA-based products, including synthetic genes, tools for next-generation sequencing (NGS) preparation, and antibody libraries for drug discovery and development. Twist is also pursuing longer-term opportunities in digital data storage in DNA and biologics drug discovery. Twist makes products for use across many industries including healthcare, industrial chemicals, agriculture and academic research.

Follow us on Twitter | Facebook | LinkedIn | YouTube

View source version on businesswire.com: https://www.businesswire.com/news/home/20230227005204/en/

For Twist Bioscience

Angela Bitting

SVP, Corporate Affairs

925- 202-6211

media@twistbioscience.com

Source: Twist Bioscience Corporation

FAQ

What investor conferences will Twist Bioscience attend in March 2023?

Twist Bioscience will present at the Cowen 43rd Annual Healthcare Conference from March 6-7, 2023, and the Barclays Global Healthcare Conference on March 14, 2023.

When is the fireside chat at the Cowen 43rd Annual Healthcare Conference?

The fireside chat at the Cowen 43rd Annual Healthcare Conference is scheduled for March 7, 2023, at 1:30 p.m. Eastern Time.

How can I access the presentations from Twist Bioscience's conferences?

The presentations from Twist Bioscience's conferences will be available for live webcast and can be accessed via the 'Investor Calendar' on their investor relations website.

What is Twist Bioscience's main focus area?

Twist Bioscience specializes in synthetic DNA manufacturing using a proprietary technology, addressing various sectors like healthcare and agriculture.

When will the fireside chat from the Barclays Global Healthcare Conference take place?

The fireside chat at the Barclays Global Healthcare Conference will occur on March 14, 2023, at 2:05 p.m. Eastern Time.